Aimovig *

  • Company:

    Novartis Ireland Limited
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14 July 2021

File name

Aimovig_REG PIL_PF21-0118_06.05.2021_clean_Nürnberg _1626246997.pdf

Reasons for updating

  • Change to section 5 - how to store or dispose

Updated on 23 June 2021

File name

Aimovig_REG SPC_PF21-0118_06.05.2021_clean_1624445990.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2020

File name

Aimovig REGSPC PF 20-0014 Clean_August 2020_1599144674.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2020

File name

Aimovig REGPIL PF 20-0014 Clean 08.2020_1599144592.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 20 February 2020

File name

Aimovig REGSPC PF 19-0192_Clean Feb 2020 medicines.ie_1582207616.pdf

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 February 2020

File name

Aimovig 70mg 140mg REGPIL PF19-0192 MT and IE Clean 02.2020 IPHA_1582030561.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 18 February 2020

File name

Aimovig REGSPC PF 19-0192_Clean Feb 2020_1582023772.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 September 2019

File name

Aimovig clean Leaflet 70mg and 140mg IPHA_1568803160.pdf

Reasons for updating

  • Correction of spelling/typing errors

Updated on 13 September 2019

File name

Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean updated_1568376159.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 02 September 2019

File name

Aimovig_Clean_Leaflet 70mg and 140mg R89 August 2019 IPHA_1567428935.pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 02 September 2019

File name

Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean_1567427858.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 May 2019

File name

Aimovig_140mg-ml_70mg_Soln_In REGPIL_26-Apr-19_English_Clean_1558706177.pdf

Reasons for updating

  • Introduction of new strength

Updated on 09 May 2019

File name

Aimovig_140mg-ml_70mg_Soln_Inj_REGSPC PF 19-0098_April 2019_Clean_1557398769.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 04 December 2018

File name

Aimovig 70mg SmPC updated 04.12.2018_1543942490.pdf

Reasons for updating

  • Change to section 3 - Pharmaceutical form

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 November 2018

File name

Aimovig 70mg 1018970_R89_p1_LFT_X-4 RA approved 22.08.2018_1541418815.pdf

Reasons for updating

  • New PIL for new product

Updated on 05 November 2018

File name

Aimovig 70mg SmPC_1541418748.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)